Evolva CEO Simon Waddington steps down as CEO with immediate effect. He will retain his financial responsibilities with the current VP Finance Alessandro Del Fabro donna forex compounding systems the financial operations. Chief Commercial Officer, will additionally assume the role of Chief Operating Officer as he will be taking responsibility also for the supply chain.
Simon, Oliver and Scott have led the planning and execution of the Company’s corporate restructuring and transformation from July 2017. D activities in the Swiss headquarters and building a strong commercial organization. As the major parts of restructuring are completed, Evolva now enters the next phase of its development with a strong focus on commercial and operational activities. On behalf of the whole Board, I would like to thank Simon for all his efforts in building Evolva during the last seven years and especially to carry out the transformation during the last twelve months. Evolva will further accelerate its activities to build the business and reach its true potential. March 20, 2018 – Evolva posted its financial results for the period from 1 January to 31 December 2017, and provided business highlights that illustrate how the Company is executing on its strategic transformation plan which was put in place last August.
Nootkatone pest control products – Evolva has filed for US EPA registration for the active ingredient nootkatone, a process that is expected to be completed by the end of 2018. In parallel, Evolva is actively engaged in discussions with leading pest control product companies to supply nootkatone for next-generation tick and mosquito products. Resveratrol products – Following on the heels of the launch of our Veri-teTM brand, revenue growth is accelerating. Symrise may be interested in the acquisition of Frutarom. Swiss francs compared to the previous year. France, is Europe, and in Asia, according to the Group’s objectives.
Frutarom Full Year 2017 Sales – March 20, 2018 – In 2017 Sales grew by 18. 4 million, constant currency pro forma growth of 6. Sales from Core Activities grew by 19. 4 million, constant currency pro forma growth of 7. Sales from Flavors activity grew by 21. Sales from Natural Specialty Fine Ingredients grew by 14.
1 million, constant currency pro forma growth of 11. Adjusted for nonrecurring expenses3 the EBITDA grew by 23. A record cash flow from operations grew by 50. Earnings per share grew by 36. Frutarom Expects 2018 to be Yet Another Record Year, as it Continues to Improve its Profitability, also through Projects for Combining Plants and Resource Optimization, and the Successful Completion of the Enzymotec Acquisition. Strong demand especially in Latin America and EAME – The largest sales growth was realized in Latin America, where sales were up by a substantial 7.